Plasma EGFR mutation abundance affects clinical response to first-line EGFR-TKIs in patients with advanced non-small cell lung cancer

BACKGROUND: Activated epidermal growth factor receptor (EGFR) mutation is the main pathogenic cause of non-small cell lung cancer (NSCLC) in Asia. However, the impact of plasma EGFR mutation abundance, especially of the ultra-low abundance of EGFR mutation detected by highly sensitive techniques on...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaohong, Liu, Yonggang, Meng, Zhiying, Wu, Yun, Wang, Shubin, Jin, Gaowa, Qin, Yingchun, Wang, Fengyun, Wang, Jing, Zhou, Haifei, Su, Xiaoxing, Fu, Xiuhua, Wang, Xiaolan, Shi, Xiaoyu, Wen, Zhenping, Jia, Xiaoqiong, Qin, Qiong, Gao, Yongqiang, Guo, Weidong, Lu, Shun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106032/
https://www.ncbi.nlm.nih.gov/pubmed/33987333
http://dx.doi.org/10.21037/atm-20-7155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106032/
https://www.ncbi.nlm.nih.gov/pubmed/33987333
http://dx.doi.org/10.21037/atm-20-7155

Ejemplares similares